2023.11.21
EventsD&E Biotechnology (4911) Shortlisted for the "National Pharmaceutical Technology R&D Award"
Topic: Development of SR-T100 Gel for the Treatment of Condyloma Acuminatum (November 21, 2023)
D&E Biotechnology participated in the 2023 "National Pharmaceutical Technology R&D Award" organized by the Taiwan Food and Drug Administration and the Industrial Development Bureau of the Ministry of Economic Affairs. The entry titled "Development of SR-T100 Gel for the Treatment of Condyloma Acuminatum" was shortlisted during the award ceremony. All staff congratulate the team on this recognition.
- Based on scientific human clinical trial data and multiple peer-reviewed papers.
- Breakthrough in current condyloma treatment bottlenecks, offering a new drug with high safety and efficacy potential.
- Completed Phase II clinical trials in Taiwan and the United States (Code: SR-T100).
D&E Official Website Product Introduction
